Status and phase
Conditions
Treatments
About
This is a open-label to assess the efficacy and safety of IM19 CAR-T cells in R/R B-cell Acute Lymphoblastic Leukemia.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
9 participants in 1 patient group
Loading...
Central trial contact
Fei Wu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal